Introduction Pharmaceutical companies will focus on coordinating and financing their acquired skills and competences. The vision is supported by the apparent instability of the "blockbuster model", rising research-development costs, the very small number of innovative products with pote
No takes yet. Share an insight, caveat, or question.
Coltescu et al. (2020) studied this question.